Chemotherapeutic potential of lupeol against cancer in pre-clinical model: A systematic review and meta-analysis

被引:0
|
作者
Fatma, Homa [1 ,2 ]
Jameel, Mohd [1 ,2 ]
Siddiqui, Arif Jamal [3 ]
Kuddus, Mohammed [4 ]
Buali, Nouha Saleh [3 ]
Bahrini, Insaf [3 ]
Siddique, Hifzur R. [1 ,2 ]
机构
[1] Mol Canc Genet & amp, Aligarh 202002, Uttar Pradesh, India
[2] Aligarh Muslim Univ, Translat Res Lab, Dept Zool, Sect Genet, Aligarh 202002, Uttar Pradesh, India
[3] Univ Hail, Coll Sci, Dept Biol, POB 2440, Hail, Saudi Arabia
[4] Univ Hail, Coll Med, Dept Biochem, Hail, Saudi Arabia
关键词
Lupeol; Chemotherapy; Chemosensitization; Meta; -analysis; Systematic review; Tumor volume; Tumor weight; DIETARY TRITERPENE; IN-VITRO; MELANOMA-CELLS; TUMOR-GROWTH; KAPPA-B; CARCINOMA; APOPTOSIS; PATHWAYS;
D O I
10.1016/j.phymed.2024.155777
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Extensive research on Lupeol's potential in cancer prevention highlights its ability to target various cancer-related factors. It regulates proliferative markers, modulates signaling pathways, including PI3K/AKT/mTOR, and influences inflammatory and apoptotic mechanisms. Additionally, Lupeol demonstrates selectivity in killing cancer cells while sparing normal cells, thus minimizing the risk of toxic effects on healthy tissues. Hypothesis: Therefore, we aimed to explore Lupeol's potential roles as a chemotherapeutic agent and as a sensitizer to chemotherapy by reviewing various animal-based studies published on its effects. Study Design: We conducted a comprehensive search across databases, including PubMed, PMC, Cochrane, EuroPMC, and ctri.gov.in to identify pertinent articles. Our focus was solely on published animal studies examining Lupeol's anti-cancer effects, with reviewers independently assessing bias risk and resolving discrepancies through consensus. Result: 20 studies were shortlisted. The results demonstrated that Lupeol brings changes in the tumor volume by [Hedges's g: -6.62; 95 % CI: -8.68, -4.56; tau(2): 24.36, I-2: 96.50 %; p < 0.05] and tumor weight by [Hedges's g: -3.97; 95 % CI: -5.20, -2.49; tau(2): 2.70, I-2: 79.27 %; p <0.05]. The high I-2, negative Egger's value, and asymmetrical funnel plot show the publication bias among the studies. Further, Lupeol in combination with other chemotherapeutic agents showed better outcomes as compared to them alone [Hedges's g: -6.38; 95 % CI: -11.82, -0.94; tau(2): 46.91; I-2: 98.68 %; p <0.05]. Lupeol also targets various signaling molecules and pathways to exert an anti-cancer effect. Conclusion: In conclusion, Lupeol significantly reduces tumor volume and weight. Combining Lupeol with other chemotherapy agents shows promise for enhancing anti-cancer effects. However, high variability among studies and evidence of publication bias suggest caution in interpreting results.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] Systematic review and meta-analysis of pre-clinical research: the need for reporting guidelines
    du Sert, Nathalie Percie
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 (19) : 2340 - 2340A
  • [2] A SYSTEMATIC REVIEW AND META-ANALYSIS OF TOPOISOMERASE INHIBITION IN PRE-CLINICAL GLIOMA MODELS
    Jue, T. J.
    Hirst, T. C.
    Sena, E. S.
    Macleod, M. R.
    McDonald, K. L.
    [J]. NEURO-ONCOLOGY, 2017, 19 : 59 - 59
  • [3] The potential of gene therapies for spinal cord injury repair: a systematic review and meta-analysis of pre-clinical studies
    Cunningham, Catriona J.
    Viskontas, Mindaugas
    Janowicz, Krzysztof
    Sani, Yasmin
    Hakansson, Malin E.
    Heidari, Anastasia
    Huang, Wenlong
    Bo, Xuenong
    [J]. NEURAL REGENERATION RESEARCH, 2023, 18 (02) : 299 - 305
  • [4] The potential of gene therapies for spinal cord injury repair:a systematic review and meta-analysis of pre-clinical studies
    Catriona J.Cunningham
    Mindaugas Viskontas
    Krzysztof Janowicz
    Yasmin Sani
    Malin E.H?kansson
    Anastasia Heidari
    Wenlong Huang
    Xuenong Bo
    [J]. Neural Regeneration Research, 2023, (02) : 299 - 305
  • [5] Treatment with inhaled Argon: a systematic review of pre-clinical and clinical studies with meta-analysis on neuroprotective effect
    Merigo, Giulia
    Florio, Gaetano
    Madotto, Fabiana
    Magliocca, Aurora
    Silvestri, Ivan
    Fumagalli, Francesca
    Cerrato, Marianna
    Motta, Francesca
    De Giorgio, Daria
    Panigada, Mauro
    Zanella, Alberto
    Grasselli, Giacomo
    Ristagno, Giuseppe
    [J]. EBIOMEDICINE, 2024, 103
  • [6] The Potential of Biomaterial-Based Approaches as Therapies for Ischemic Stroke: A Systematic Review and Meta-Analysis of Pre-clinical Studies
    Bolan, Faye
    Louca, Irene
    Heal, Calvin
    Cunningham, Catriona J.
    [J]. FRONTIERS IN NEUROLOGY, 2019, 10
  • [7] Mesenchymal stem cells in autoimmune disease: A systematic review and meta-analysis of pre-clinical studies
    Swain, Hailey N.
    Boyce, Parker D.
    Bromet, Bradley A.
    Barozinksy, Kaiden
    Hance, Lacy
    Shields, Dakota
    Olbricht, Gayla R.
    Semon, Julie A.
    [J]. BIOCHIMIE, 2024, 223 : 54 - 73
  • [8] Cholesterol esterification enzymes promote cancer growth and are potential therapeutic targets for repurposed drugs: a systematic review and meta-analysis of pre-clinical evidence
    Websdale, A.
    Chalmers, P.
    Chen, X.
    Kiew, Y.
    Luo, X.
    Mwarazi, R.
    Wu, R.
    Cioccoloni, G.
    Roberg-Larsen, H.
    Hughes, T. A.
    Zulyniak, M. A.
    Thorne, J. L.
    [J]. PROCEEDINGS OF THE NUTRITION SOCIETY, 2021, 80 (OCE5)
  • [9] A SYSTEMATIC REVIEW AND META-ANALYSIS OF MINOCYCLINE EFFICACY IN PRE-CLINICAL TRAUMATIC BRAIN INJURY MODELS
    Palomino, Jhonel
    Bellander, Bo-Michael
    Hanell, Anders
    [J]. JOURNAL OF NEUROTRAUMA, 2018, 35 (16) : A200 - A200
  • [10] Investigation of S-Nitrosoglutathione in Stroke: A Systematic Review and Meta-Analysis of Literature in Pre-clinical and Clinical Research
    Liu, Shimeng
    Zheng, Haiqing
    Yu, Wengui
    Ramakrishnan, Viswanathan
    Shah, Shreyansh
    Gonzalez, Louis Fernando
    Singh, Inderjit
    Graffagnino, Carmelo
    Feng, Wuwei
    [J]. NEUROLOGY, 2020, 94 (15)